Categorised under:
Interventional Radiology
>
Oncology
>
Selective Internal Radiation Therapy
SARAH Study completes enrollment for HCC trial, results expected in 2016
Sirtex Medical Limited, a manufacturer of targeted innovative liver cancer therapies has announced the completion of patient recruitment into the group's landmark SIRFLOX randomised controlled trial of SIR-Spheres microspheres, for patients with metastatic colorectal cancer.
Did you know you can Register for FREE with this website?
Registration gives you full access to all of the features of WhichMedicalDevice. Find out more ...
WhichMedicalDevice is a FREE resource created by clinicians for clinicians.
Registration is free and gives you unlimited access to all of the content and features of this website.
Find out more...Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...
Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.
We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.